You are here:
NICE
NICE Guidance
Conditions and diseases
Neurological conditions
Multiple sclerosis
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis
Technology appraisal guidance
Reference number:
TA127
Published:
22 August 2007
Guidance
Tools and resources
Information for the public
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA127